OptimizeRx Corp — Director's Dealing 2020

Sep 4, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2020-09-02

Reporting Person: BAKER DOUGLAS P (CHIEF FINANCIAL OFFICER)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-09-02	Common Stock	S	10000	$20	Disposed	80705	Direct
2020-09-02	Common Stock	M	10000	$2.46	Acquired	90705	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-09-02	Stock Option	$2.46	M	10000	Disposed	2022-03-31	Common Stock (10000)	Direct

Footnotes

F1: These shares sold pursuant to a plan of disposition adopted on June 16, 2020 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.